Apryl N. Peddi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Apryl N. Peddi has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Alexis N. Crawford
School of Pharmacy, Virginia Commonwealth University, Richmond, VA, United States of America
2 shared publications - Brittany L. Riley
School of Pharmacy, Marshall University, One John Marshall University, Huntington, WV 25755, United States of America
2 shared publications - John D. Bucheit
Virginia Commonwealth University School of Pharmacy, Richmond, Virginia
2 shared publications - Julie A. Patterson
Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, 410 N. 12th St., P.O. Box 980581, Richmond, VA 23298, United States
2 shared publications - Krista L. Donohoe
Virginia Commonwealth University School of Pharmacy
2 shared publications - Lauren M. Caldas
Virginia Commonwealth University School of Pharmacy
2 shared publications
Latest Publications
- 4 October 2025
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 89 (11) , 101877
Comparison of Peer, Near-Peer, and AI-Assisted Methods to Faculty Grading of SOAP Notes
- 4 October 2025
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 89 (11) , 101877
Comparison of Peer, Near-Peer, and AI-Assisted Methods to Faculty Grading of SOAP Notes
- 1 July 2025
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 86 (1) , 11-18
Aprocitentan for Treatment-Resistant Hypertension: Pharmacology Concepts and Clinical Insights
Treatment-resistant hypertension (TRH) occurs in approximately 20% of patients with a diagnosis of hypertension despite receiving 3 or more antihypertensives and places individuals at an increased risk of morbidity and mortality compared with essential hypertension. Numerous pathophysiologic factors underlie TRH, including endothelin-1, which until recently no approved treatments targeted. Endothelin-1 exhibits multiple actions through binding to ETA and ETB receptors. Vasoconstriction of the vascular smooth muscle occurs when endothelin-1 binds ETA and ETB; however, vasodilation of endothelial cells also occurs through activation of ETB. Currently available endothelin receptor antagonists (ERA) were only approved for pulmonary hypertension until 2024 when the Food and Drug Administration approved aprocitentan as the first ERA for hypertension treatment in combination with other antihypertensives. The approval of aprocitentan occurred after the publication of the phase 3 PRECISION trial that compared aprocitentan versus placebo for patients with “true” TRH. Aprocitentan 12.5 mg exhibited a placebo-adjusted reduction in sitting systolic and diastolic blood pressure of 3.8/3.9 mm Hg at 4 weeks of treatment. A dose-dependent increase in peripheral edema and a small reduction in hemoglobin due to hemodilution were greater in the aprocitentan-treated patients. Animal study data from past ERA showed this class of agents may lead to birth defects and was the basis for aprocitentan's black box warning. Overall, clinical trial data support aprocitentan's use as an effective agent for the TRH, but clinicians will need to individualize patient treatment selection and consider the safest and most efficacious options currently available.
- 1 July 2025
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 86 (1) , 11-18
Aprocitentan for Treatment-Resistant Hypertension: Pharmacology Concepts and Clinical Insights
Treatment-resistant hypertension (TRH) occurs in approximately 20% of patients with a diagnosis of hypertension despite receiving 3 or more antihypertensives and places individuals at an increased risk of morbidity and mortality compared with essential hypertension. Numerous pathophysiologic factors underlie TRH, including endothelin-1, which until recently no approved treatments targeted. Endothelin-1 exhibits multiple actions through binding to ETA and ETB receptors. Vasoconstriction of the vascular smooth muscle occurs when endothelin-1 binds ETA and ETB; however, vasodilation of endothelial cells also occurs through activation of ETB. Currently available endothelin receptor antagonists (ERA) were only approved for pulmonary hypertension until 2024 when the Food and Drug Administration approved aprocitentan as the first ERA for hypertension treatment in combination with other antihypertensives. The approval of aprocitentan occurred after the publication of the phase 3 PRECISION trial that compared aprocitentan versus placebo for patients with “true” TRH. Aprocitentan 12.5 mg exhibited a placebo-adjusted reduction in sitting systolic and diastolic blood pressure of 3.8/3.9 mm Hg at 4 weeks of treatment. A dose-dependent increase in peripheral edema and a small reduction in hemoglobin due to hemodilution were greater in the aprocitentan-treated patients. Animal study data from past ERA showed this class of agents may lead to birth defects and was the basis for aprocitentan's black box warning. Overall, clinical trial data support aprocitentan's use as an effective agent for the TRH, but clinicians will need to individualize patient treatment selection and consider the safest and most efficacious options currently available.
- 23 April 2025
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 17 (7) , 102367
Artificial intelligence (AI) performance on pharmacy skills laboratory course assignments
- 23 April 2025
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 17 (7) , 102367
Artificial intelligence (AI) performance on pharmacy skills laboratory course assignments
- 23 April 2025
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 17 (7) , 102350
Insights from a survey on professional identity formation activities in pharmacy skills laboratory courses
- 23 April 2025
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 17 (7) , 102350
Insights from a survey on professional identity formation activities in pharmacy skills laboratory courses
- Open Access
- 26 November 2024
- Published by University of Minnesota in INNOVATIONS in pharmacy
- Vol. 15 (4) , 10
Development and Assessment of an Online, Asynchronous State-Specific Pharmacy Law Continuing Education Program for Multistate Pharmacy Jurisprudence Examination Preparation
Inspiring Inquiry and Improvement in Pharmacy Practice, Education, and Policy A quarterly publication featuring case studies, clinical experiences, commentaries, idea papers, original research, and review articles that focus on the leading edge, novel ideas for improving, modernizing, and advancing pharmacy practice, education, and policy. INNOVATIONS in pharmacy is an academic, peer reviewed, open-access journal. Sponsored by U of MN College of Pharmacy Inspiring Inquiry and Improvement in Pharmacy Practice, Education, and Policy. A quarterly publication featuring case studies, clinical experiences, commentaries, idea papers, original research, review articles, and student projects that focus on leading edge, novel ideas for improving, modernizing, and advancing pharmacy practice, education, and policy. INNOVATIONS in pharmacy.
- 26 November 2024
- Published by University of Minnesota in INNOVATIONS in pharmacy
- Vol. 15 (4) , 10
Open AccessDevelopment and Assessment of an Online, Asynchronous State-Specific Pharmacy Law Continuing Education Program for Multistate Pharmacy Jurisprudence Examination Preparation
Inspiring Inquiry and Improvement in Pharmacy Practice, Education, and Policy A quarterly publication featuring case studies, clinical experiences, commentaries, idea papers, original research, and review articles that focus on the leading edge, novel ideas for improving, modernizing, and advancing pharmacy practice, education, and policy. INNOVATIONS in pharmacy is an academic, peer reviewed, open-access journal. Sponsored by U of MN College of Pharmacy Inspiring Inquiry and Improvement in Pharmacy Practice, Education, and Policy. A quarterly publication featuring case studies, clinical experiences, commentaries, idea papers, original research, review articles, and student projects that focus on leading edge, novel ideas for improving, modernizing, and advancing pharmacy practice, education, and policy. INNOVATIONS in pharmacy.
- 10 August 2024
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 88 (9) , 101259
Counting on Change: Conquering Challenges in Teaching Pharmaceutical Calculations
- 10 August 2024
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 88 (9) , 101259
Counting on Change: Conquering Challenges in Teaching Pharmaceutical Calculations
- 19 June 2023
- Published by SAGE Publications in Journal of Pharmacy Technology
- Vol. 39 (4) , 164-171
Teaching Independent Decision-Making Through a Computer-Based Drug Utilization Review Simulation
Background: Drug utilization review (DUR) skills are important for pharmacists across all settings. Computer-based DUR simulations to teach student pharmacists are currently scarce. This article describes a computer-based DUR simulation that required limited faculty and financial resources and was implemented in collaboration among 3 institutions. Objective: To describe the innovation of a computer-based DUR simulation and its impact on pharmacy students’ knowledge and confidence of DUR skills. Methods: This pre-post educational study assessed a computer-based DUR simulation that replicated the DUR process in dispensing systems. First- and third-year pharmacy students at 3 institutions were guided through simulated patient cases with various medication-related problems. The self-paced activity provided students with immediate, formative feedback and rationale for each option after an attempt was made in lieu of faculty intervention. Students completed pre-and post-assessments to evaluate changes in knowledge and confidence. Knowledge was assessed by comparing results of multiple choice and matching questions on the pre- and post-assessments. Confidence was assessed by the change in self-reported confidence scale measurements. Results: Students at all institutions (N = 405) had nonsignificant changes in knowledge scores from the pre-assessment to the post-assessment, with the exception of 1 question. All confidence survey questions significantly improved from pre- to post-assessment. Conclusion: The DUR educational innovation had a nonsignificant overall impact on students’ knowledge but significantly improved confidence in their abilities. Skills-based instruction provides additional practice to increase student confidence.
- 19 June 2023
- Published by SAGE Publications in Journal of Pharmacy Technology
- Vol. 39 (4) , 164-171
Teaching Independent Decision-Making Through a Computer-Based Drug Utilization Review Simulation
Background: Drug utilization review (DUR) skills are important for pharmacists across all settings. Computer-based DUR simulations to teach student pharmacists are currently scarce. This article describes a computer-based DUR simulation that required limited faculty and financial resources and was implemented in collaboration among 3 institutions. Objective: To describe the innovation of a computer-based DUR simulation and its impact on pharmacy students’ knowledge and confidence of DUR skills. Methods: This pre-post educational study assessed a computer-based DUR simulation that replicated the DUR process in dispensing systems. First- and third-year pharmacy students at 3 institutions were guided through simulated patient cases with various medication-related problems. The self-paced activity provided students with immediate, formative feedback and rationale for each option after an attempt was made in lieu of faculty intervention. Students completed pre-and post-assessments to evaluate changes in knowledge and confidence. Knowledge was assessed by comparing results of multiple choice and matching questions on the pre- and post-assessments. Confidence was assessed by the change in self-reported confidence scale measurements. Results: Students at all institutions (N = 405) had nonsignificant changes in knowledge scores from the pre-assessment to the post-assessment, with the exception of 1 question. All confidence survey questions significantly improved from pre- to post-assessment. Conclusion: The DUR educational innovation had a nonsignificant overall impact on students’ knowledge but significantly improved confidence in their abilities. Skills-based instruction provides additional practice to increase student confidence.
- Open Access
- 1 May 2023
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 6 (5) , 528-554
Overview of implementation and learning outcomes of simulation in pharmacy education
Simulation, an educational, assessment, and research technique used to mimic real‐world situations, is increasingly used in pharmacy education. The most‐used simulation methods include high‐fidelity simulation (HFS), low‐fidelity simulation (LFS), standardized patients, and game‐based simulation. A common element of simulation is its ability to offer learners the chance to practice a skill or acquire knowledge in a safe and accessible space. Simulation methods differ in key aspects, including cost and other resource investment as well as ideal venue for use in education. HFS provides a more realistic simulation environment than LFS but is typically more expensive. Standardized patients offer learners the opportunity to engage with a live person but may elicit greater variability in responses to learners' input than HFS. Computer‐based simulation uses technology to supply a wide variety of learning opportunities; however, it may require the use of proprietary software and devices. Despite widespread use, literature describing learning outcomes of simulation in pharmacy education is limited. Some existing reports with positive findings have focused on learner satisfaction with or perceived benefit of simulation activities. The few existing publications summarizing changes in skills or knowledge demonstrate a positive impact. Simulation is a promising modality for educating pharmacy students and residents; however, more data summarizing the benefit of learning outcomes are needed.
- 1 May 2023
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 6 (5) , 528-554
Open AccessOverview of implementation and learning outcomes of simulation in pharmacy education
Simulation, an educational, assessment, and research technique used to mimic real‐world situations, is increasingly used in pharmacy education. The most‐used simulation methods include high‐fidelity simulation (HFS), low‐fidelity simulation (LFS), standardized patients, and game‐based simulation. A common element of simulation is its ability to offer learners the chance to practice a skill or acquire knowledge in a safe and accessible space. Simulation methods differ in key aspects, including cost and other resource investment as well as ideal venue for use in education. HFS provides a more realistic simulation environment than LFS but is typically more expensive. Standardized patients offer learners the opportunity to engage with a live person but may elicit greater variability in responses to learners' input than HFS. Computer‐based simulation uses technology to supply a wide variety of learning opportunities; however, it may require the use of proprietary software and devices. Despite widespread use, literature describing learning outcomes of simulation in pharmacy education is limited. Some existing reports with positive findings have focused on learner satisfaction with or perceived benefit of simulation activities. The few existing publications summarizing changes in skills or knowledge demonstrate a positive impact. Simulation is a promising modality for educating pharmacy students and residents; however, more data summarizing the benefit of learning outcomes are needed.
- 1 November 2021
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 13 (11) , 1538-1543
Lessons learned: Assessing team creation by personality inventories in pharmacy students
- 1 November 2021
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 13 (11) , 1538-1543
Lessons learned: Assessing team creation by personality inventories in pharmacy students
- Open Access
- 30 June 2019
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 17 (2) , 1581
Pharmacist-administered pediatric vaccination services in the United States: major barriers and potential solutions for the outpatient setting
Pharmacy Practice is a free full-text journal with a scope on the practice of pharmacy. Pharmacy Practice covers pharmaceutical care, social pharmacy, pharmacy education, process and outcome research, health promotion and education, health informatics, pharmacoepidemiology
- 30 June 2019
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 17 (2) , 1581
Open AccessPharmacist-administered pediatric vaccination services in the United States: major barriers and potential solutions for the outpatient setting
Pharmacy Practice is a free full-text journal with a scope on the practice of pharmacy. Pharmacy Practice covers pharmaceutical care, social pharmacy, pharmacy education, process and outcome research, health promotion and education, health informatics, pharmacoepidemiology